Fletcher Spaght
Fletcher Spaght is a venture capital firm that provides growth strategies for medtech, life sciences, healthcare and high technology companies.
Business Model: B2C
Revenue: $5.7M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Fletcher Spaght Information
Geographic Data
Address: 222 Berkeley St
City: Boston
State: MA
Zip: 02116
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$350k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Fletcher Spaght is a venture capital firm that provides growth strategies for medtech, life sciences, healthcare and high technology companies.
Contact Phone:
+16172476700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2012 | Cayenne Medical | Venture Round | 10M |
| 7/2005 | Quick Study Radiology | Series C | 0 |
| 6/2012 | PhaseBio Pharmaceuticals | Series B | 23M |
| 7/2011 | SurgiQuest | Series C | 19M |
| 2/2006 | Courtagen Life Sciences | Venture Round | 7.6M |
| 8/2011 | Metabolon | Series D | 0 |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 2/2011 | CardioFocus | Series C | 0 |
| 9/2017 | Cheetah Medical | Series C | 0 |
| 2/2003 | Ventaira Pharmaceuticals | Series B | 0 |
| 2/2014 | Cheetah Medical | Series C | 0 |
| 5/2014 | CardioFocus | Debt Financing | 0 |
| 1/2014 | Metabolon | Series E | 0 |
| 12/2012 | SurgiQuest | Series D | 0 |
| 3/2006 | BioTrove | Venture Round | 7M |
| 4/2016 | Swift Biosciences | Series C | 0 |
| 3/2015 | PhaseBio Pharmaceuticals | Series C | 0 |
| 3/2017 | HistoSonics | Series B | 0 |
| 2/2010 | HistoSonics | Series A | 0 |
| 1/2010 | PhaseBio Pharmaceuticals | Series B | 25M |
| 4/2005 | Ventaira Pharmaceuticals | Series C | 0 |
| 7/2012 | Juventas Therapeutics | Series B | 0 |
| 10/2013 | Swift Biosciences | Series B | 0 |
| 10/2007 | Interactive Supercomputing | Series B | 11M |
| 1/2007 | Quick Study Radiology | Series D | 0 |
| 12/2009 | Metabolon | Series C | 6M |
| 10/2004 | Quick Study Radiology | Series C | 0 |
| 9/2018 | PhaseBio Pharmaceuticals | Series D | 0 |
| 8/2011 | SironRX Therapeutics | Series A | 3.4M |
| 10/2007 | PhaseBio Pharmaceuticals | Venture Round | 6.6M |
| 10/2005 | GlycoFi Inc. | Series C | 11M |
| 7/2011 | HTG Molecular Diagnostics | Series D | 0 |
| 9/2018 | PhaseBio Pharmaceuticals | Series D | 0 |
| 9/2017 | Cheetah Medical | Series C | 0 |
| 3/2017 | HistoSonics | Series B | 0 |
| 4/2016 | Swift Biosciences | Series C | 0 |
| 3/2015 | PhaseBio Pharmaceuticals | Series C | 0 |
| 5/2014 | CardioFocus | Debt Financing | 0 |
| 2/2014 | Cheetah Medical | Series C | 0 |
| 1/2014 | Metabolon | Series E | 0 |
| 10/2013 | Swift Biosciences | Series B | 0 |
| 12/2012 | SurgiQuest | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Debt | $350k |
U.S. Small Business Administration. |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
